A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
Scientists at the University of Tsukuba reveal that brain refreshing takes place during the dreaming phase of sleep, aka rapid eye movement (REM) sleep.
Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.
Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
Neuroscientists have discovered the closest thing to the infamous "grandmother neuron" - they have identified the cells responsible for how the brain remembers faces.
Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.
Professor Sergio Bertolucci, Chair of the ATTRACT R&D&I Committee (IC), explores how the ATTRACT Project is bridging the gap between research and industry to go from Open Science to Open Innovation.
Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.
The team examined a mix of factors such as pollution, crime, access to education and healthcare - they found that in over 7,000 children, these factors directly impacted brain development.
A team at the Karolinska Institutet found that some patients who recovered by accessing depression treatment showed an increase in their average level of serotonin transporter.
